A Five-Year Roadmap for AI-Powered Medical Imaging Analytics

The challenge

A developer of artificial intelligence (AI)-powered medical imaging analytics for early detection of cardiac and bone disease sought to define a go-to-market strategy for the U.S. market with return on investment (ROI) quantification. The client aimed to equip its sales team with evidence-based materials, including clinical use cases for health systems and guidance on optimal product and service bundles.

L.E.K. Consulting was selected for its deep medtech and AI expertise to design a clear, phased strategy that would accelerate adoption and position the client for long-term success.

At a glance, our client:

• Needed a structured U.S. go-to-market plan to drive adoption of AI-powered analytics with ROI quantification
• Sought to equip the commercial team with targeted sales materials and clinical use cases
• Wanted to align near-term commercialization with a scalable, long-term innovation roadmap
   

Our approach

We developed a five-year go-to-market strategy organized into distinct phases, each designed to build commercial readiness and scale market adoption over time.

Year 1: foundation building

The first year focuses on laying the groundwork — onboarding early adopters, building infrastructure, compiling data and engaging key medical societies to secure buy-in.

Years 2–3: evidence and adoption

The next phase emphasizes generating clinical evidence and accelerating adoption through targeted sales efforts, reimbursement readiness and a physician referral playbook to capture best practices.

Years 4–5: broader adoption and support

These years outline plans to scale adoption across health systems, expand support services and strengthen market credibility through reimbursement preparation.

Beyond Year 5: continuous innovation and scaling

Beyond five years, the roadmap calls for ongoing innovation — expanding features, enhancing services and investing in infrastructure to maintain leadership in AI medical imaging.

Key elements of the approach:

• Structured a phased, five-year roadmap with ROI evaluation
• Combined AI, clinical and market insights to guide adoption and expansion
• Developed tailored sales materials and playbooks to enable execution across teams

The results

Our strategy positioned the AI imaging company for sustained success in the U.S. market. The client received a clear, time-based roadmap detailing market entry, customer targeting and commercialization milestones, supported by tactical sales tools and evidence-building plans.

The roadmap not only prepared the company for near-term launch but also ensured readiness for continuous innovation and scaling beyond the first five years.

Impact delivered:

• Provided a five-year strategic roadmap linking clinical, commercial and operational goals
• Enabled data-driven market entry supported by tailored sales and evidence tools
• Positioned the company for scalable, long-term growth in AI-powered medical imaging

L.E.K. Consulting is a registered trademark of L.E.K. Consulting LLC. All other products and brands mentioned in this document are properties of their respective owners. © 2025 L.E.K. Consulting LLC